{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:55:07Z","timestamp":1787813707950,"version":"build-2784847793"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"abstract":"\n Background:<\/jats:title>\n Rheumatoid arthritis is a chronic and systemic inflammatory disorder, in which Lipoprotein (a) [Lp (a)] increases plaque formation and thus promotes atherosclerosis. Coronary artery disease is one of the co-morbidity in rheumatoid arthritis patients.<\/jats:p>\n <\/jats:sec>\n \n Aim:<\/jats:title>\n The aim of this study is to evaluate Lp (a) as a cardiovascular risk factor in patients with rheumatoid arthritis. This was a comparative study in which Lp (a) and lipid profile were compared in rheumatoid arthritis patients and controls.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n The study included 30 sero-positive rheumatoid arthritis patients and 30 normal healthy subjects with an age and sex matched group of 25\u201380 years. Statistical analysis was performed using SPSS version 17.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Serum Lp (a) concentration was significantly increased (\n P<\/jats:italic>\n < 0.001) in rheumatoid arthritis patients compared with controls. Serum high-density lipoprotein-cholesterol was significantly lowered (\n P<\/jats:italic>\n < 0.05) in patients as compared to controls. There was no significant difference in serum total cholesterol, triglycerides, and very low density lipoprotein-cholesterol between patients and controls.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n The findings indicate that the patients with rheumatoid arthritis are at high risk of developing cardiovascular disease in future due to the increased level of Lp (a). In addition to conventional lipid profile, estimation of Lp (a) can prove to be a valuable tool in risk assessment of population in general and management of disease in particular.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/0975-7406.155767","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T05:42:03Z","timestamp":1430199723000},"page":"S22-S25","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["A comparative study on serum lipoprotein (a) and lipid profile between rheumatoid arthritis patients and normal subjects"],"prefix":"10.4103","volume":"7","author":[{"given":"K. P. Shiva","family":"Govindan","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Melmaruvathur Adhiparasakthi Institute of Medical Science and Research, Melmaruvathur, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Basha","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Melmaruvathur Adhiparasakthi Institute of Medical Science and Research, Melmaruvathur, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ramesh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Sri Lakshmi Narayana Institute of Medical Sciences, Puducherry, Affiliated to Bharath University, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Naveen","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Sri Lakshmi Narayana Institute of Medical Sciences, Puducherry, Affiliated to Bharath University, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Swathi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Madha Dental College, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250922","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/ard.2005.050377","article-title":"Patterns of cardiovascular risk in rheumatoid arthritis","volume":"65","author":"Solomon","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R2-20250922","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"R3-20250922","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R4-20250922","first-page":"343","article-title":"Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America","volume":"48","author":"Enas","year":"1996","journal-title":"Indian Heart J"},{"key":"R5-20250922","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1749-6632.2001.tb03514.x","article-title":"Inhibition of fibrinolysis by lipoprotein (a)","volume":"936","author":"Angl\u00e9s-Cano","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"R6-20250922","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.1996.03540110029028","article-title":"Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women","volume":"276","author":"Gardner","year":"1996","journal-title":"JAMA"},{"key":"R7-20250922","first-page":"76","article-title":"Role of dyslipidaemia in cardiovascular diseases and the therapeutic benefits by the appropriate drugs","volume":"8","author":"Banoo","year":"2001","journal-title":"Rev Artic Orion"},{"key":"R8-20250922","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02867675","article-title":"Serum lipoprotein (a) and lipid profile in young South Indian patients with myocardial infarction","volume":"18","author":"Angeline","year":"2003","journal-title":"Indian J Clin Biochem"},{"key":"R9-20250922","first-page":"27","article-title":"Lipoprotein (a) in relation to atherosclerotic diseases","volume":"255","author":"Dahlen","year":"1988","journal-title":"Prog Clin Biol Res"},{"key":"R10-20250922","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation"},{"key":"R11-20250922","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.50.6.366","article-title":"Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis","volume":"50","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"R12-20250922","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1021\/bi00767a015","article-title":"Protein and carbohydrate composition of Lp (a) lipoprotein from human plasma","volume":"11","author":"Ehnholm","year":"1972","journal-title":"Biochemistry"},{"key":"R13-20250922","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis - An inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"R14-20250922","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00296-004-0438-0","article-title":"Lp (a) lipoprotein and lipids in patients with rheumatoid arthritis: Serum levels and relationship to inflammation","volume":"25","author":"Dursunoglu","year":"2005","journal-title":"Rheumatol Int"},{"key":"R15-20250922","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0049-0172(05)80030-7","article-title":"Antilipoprotein antibodies in rheumatoid arthritis","volume":"22","author":"Lazarevic","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"R16-20250922","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0009-9120(88)80094-8","article-title":"Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis","volume":"21","author":"Lakatos","year":"1988","journal-title":"Clin Biochem"},{"key":"R17-20250922","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp (a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N Engl J Med"},{"key":"R18-20250922","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1538-7836.2008.03183.x","article-title":"Apolipoprotein (a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: A novel mechanism for lipoprotein (a)-mediated inhibition of plasminogen activation","volume":"6","author":"Feric","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R19-20250922","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein (a) as a cardiovascular risk factor: Current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"R20-20250922","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/rheumatology\/40.6.640","article-title":"Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis","volume":"40","author":"McEntegart","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"R21-20250922","first-page":"35","article-title":"The relationship between rheumatoid arthritis and heart failure","volume":"12","author":"Briggs","year":"2011","journal-title":"J Manag Care Med"},{"key":"R22-20250922","first-page":"137","article-title":"Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment","volume":"46","author":"Agoston-Coldea","year":"2008","journal-title":"Rom J Intern Med"},{"key":"R23-20250922","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0009-3084(94)90164-3","article-title":"Lp (a): An acute-phase reactant?","volume":"67-68","author":"Noma","year":"1994","journal-title":"Chem Phys Lipids"},{"key":"R24-20250922","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/art.10359","article-title":"Atherosclerosis in rheumatoid arthritis: Morphologic evidence obtained by carotid ultrasound","volume":"46","author":"Park","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R25-20250922","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5","article-title":"Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: Possible contribution of phospholipase A2 to this atherogenic profile","volume":"44","author":"Hurt-Camejo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R26-20250922","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"J Am Med Assoc"},{"key":"R27-20250922","first-page":"71","article-title":"Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: An 8 year followup study","volume":"27","author":"W\u00e5llberg-Jonsson","year":"2000","journal-title":"J Rheumatol"},{"key":"R28-20250922","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R29-20250922","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/art.23798","article-title":"The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population","volume":"58","author":"Davis","year":"2008","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01438291-201507001-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:46:30Z","timestamp":1787067990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01438291-201507001-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":29,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4103\/0975-7406.155767","relation":{},"ISSN":["0976-4879","0975-7406"],"issn-type":[{"value":"0976-4879","type":"print"},{"value":"0975-7406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"2014-10-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-11-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}